Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| ARROW FINANCIAL CORPAROW · Entity 5233 | Director | January 25, 2017 | January 26, 2017 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
ARROW FINANCIAL CORP
Report date January 25, 2017 · Filed January 26, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Director Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $37.20 · Expires 2027-01-25 | Direct | 1,000 |
Reported balance
After 2017-01-25 transaction · row 2
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 2 · 2017-01-25 · Grant · Acquired 1,000 · Balance 1,000 F2: The options vest in four equal installments beginning January 25, 2018 |
| Common StockSEC Table I · non-derivative | Direct | 7,580 |
Reported balance
Holding disclosure · report date 2017-01-25 · row 1
Holding and transaction disclosures are not merged.
1 source rowRow 1 · Balance 7,580 F1: The information provided reflects 48 shares acquired under the Company's DRIP since November 30, 2016 which were not required to be reported on a Form 4. This information is being furnished to disclose the total holdings of the insider as of the date of this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The information provided reflects 48 shares acquired under the Company's DRIP since November 30, 2016 which were not required to be reported on a Form 4. This information is being furnished to disclose the total holdings of the insider as of the date of this Form 4.
F2: The options vest in four equal installments beginning January 25, 2018
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| January 25, 2017 Filed Jan 26, 2017 23:23 UTC | ARROW FINANCIAL CORP AROW · Entity 5233 | GrantDirector Stock Option (Right to Buy) · Derivative | 1,000 | $0.00 Strike: $37.20 | $0.00 |
DisclosureSEC source: 0000717538-17-000028 · wf-form4_148547300085223.xml · derivative · entry 2 CARUSONE JOHN J JR · CIK 0001187056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,000 Underlying: Common Stock · 1,000 shares Expires 2027-01-25 F2 · derivative.exercise_date: The options vest in four equal installments beginning January 25, 2018 Read SEC document |
| November 30, 2016 Filed Dec 1, 2016 21:26 UTC | ARROW FINANCIAL CORP AROW · Entity 5233 | OtherCommon Stock | 204 | $37.85 | $7,721.40 |
DisclosureSEC source: 0000717538-16-000380 · wf-form4_148062755650058.xml · nonDerivative · entry 1 CARUSONE JOHN J JR · CIK 0001187056 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,532 F1 · balance_after: The information provided reflects 113 shares acquired under the Company's DRIP since and 213 shares acquired via a stock dividend since May 26, 2016 which were not required to be reported on a Form 4. This information is being furnished to disclose the total holdings of the insider as of the date of this Form 4. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.